首页> 外文OA文献 >Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation

【2h】

Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation

机译：创伤性损伤：阻止口腔颤动口服抗凝的另一种不合理的原因

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sean D Pokorney; Christopher B Granger;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation [J] . Sean DPokorney, Christopher BGranger European Heart Journal: The Journal of the European Society of Cardiology . 2018,第19期

机译：创伤损伤：阻止口腔颤动口服抗凝的另一种不合理的原因
2. Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study [J] . LailaStaerk, Emil LoldrupFosb?l, MortenLamberts, European Heart Journal: The Journal of the European Society of Cardiology . 2018,第19期

机译：口腔损伤后口腔抗凝的恢复和心房颤动患者中风和中风和出血的风险：全国队列队列研究
3. Reasons for non-prescription of oral anticoagulation in patients discharged with ischaemic stroke and atrial fibrillation: a case-series review [J] . Creaney Calum, Barkat Karissa, Durey Christopher, Scottish medical journal . 2019,第3期

机译：用缺血性卒中和心房颤动患者口服抗凝非处方的原因：案例系列审查
4. Anticoagulation in Conventional Versus Transesophageal Echocardiography (TEE) Guided Cardioversion (CV) of Atrial Fibrillation (AF) [C] . A. Dokler Glavnik, P. Zohar, R. Gunzek, International Congress on Thrombosis . 2004

机译：常规与经细胞激素超声心动图（TEE）引导的心房颤动（AF）引导型心致（CV）的抗凝
5. Early Identification and Intervention in Patients with Atrial Fibrillation Using an Implantable Cardiac Monitor to Significantly Improve Guideline-Based Anticoagulation Therapy in an Outpatient Cardiology Clinic [D] . Alvarez, Lisa 2019

机译：使用可植入式心脏监护仪对房颤患者的早期识别和干预，可显着改善门诊心脏病学诊所基于指南的抗凝治疗
6. Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group open-label blinded-endpoint superiority multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting [O] . Lisa Riesinger, Claudia Strobl, David M. Leistner, 2021

机译：Apixaban与苯procoumon：口服抗凝加抗血小板治疗急性冠状动脉综合征和心房颤动的患者（方法-ACS-AF）：理论和设计前瞻性随机平行开放标签盲 - 终点优势多中心试验对心房颤动患者的三重治疗与双重治疗和急性冠状动脉综合征接受冠状动脉抵抗
7. Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts” [O] . Jonathan P. Piccini, Susanna R. Stevens, YuChiao Chang, 2013

机译：回应关于物品的信，“肾功能障碍是非衰弱性心房颤动患者中风和全身栓塞的预测因子：验证R 2 Chads 2指数在火箭AF中（rivaroxaban曾经每日，口服，直接因子XA抑制相比维生素K对患者预防心房颤动的卒中和栓塞试验的拮抗剂）和Atria（心房颤动的抗凝和危险因素）研究队列“

Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation

著录项

引文网络

相似文献

相关主题

期刊订阅